Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

Investors often mistake share price for valuation. While Eli Lilly's stock price looks expensive on the surface, the ...

When the New York Times recently posted a fluffy profile of billionaire socialite Lauren Sánchez Bezos, Katie Couric couldn’t ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

Eli Lilly and Company (NYSE:LLY) is one of the top S&P 500 stocks by index weight. On April 15, BMO Capital reiterated an ...

The Trump administration has dropped a plan for insurers to provide cheap weight loss drugs to seniors through a Medicare ...

Eli Lilly and Rigel Pharmaceuticals partnered in February 2021 to advance a pair of RIPK1 blockers, but the pharma in October ...

The deals keep rolling in, with Lilly penning a $7 billion pact for gene delivery biotech Kelonia Therapeutics and UCB taking ...

Amazon is offering a GLP-1 weight loss program that doesn't require membership. "Amazon.com to Offer Program for GLP-1 Weight-Loss Drugs," published at 3:15 p.m. on April 21, implied that members can ...

Eli Lilly and Company will collaborate with the state on a future pathway for nuclear energy solutions, including small ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?